"Euromed, our company in Israel" , as per Doc himself,
"Euromed, our company in Israel" , as per Doc himself,
I myself am looking forward to what Doc has lined up with Euromed
https://investorshangout.com/post/view?id=5782951
Euromed Pharma is the most recent company launched by the Petrone Group, a family-owned business at its 3rd generation of continuous development. Carmine Petrone, the founding father of this enterprise, still walks the aisles of the company´s headquarters and provides support to his three sons who now lead the organization.
The Petrone Group is a conglomerate of thirty companies, a thousand employees, a network of pharmacies, three wholesale national distributors, a clinical manufacturing facility, nine rehabilitation centers in Naples, and a series of other specialty providers all focused on the health and pharmaceutical sector with a prosperous international activity and foreign offices in, Italy, Spain, Ireland, Singapore, and the United States
https://www.euromed-pharma.com/
EuroMed Pharma Group B.V.
EuroMed Pharma Group B.V.
Julianalaan 34
6191 AM, Beek LB , LIMBURG Netherlands
+31-464371885
Company Type: Private Limited Company Subsidiary
EuroMed Pharma Group B.V. is located in Beek LB, LIMBURG, Netherlands and is part of the Drug Wholesalers Industry. EuroMed Pharma Group B.V. has 1 employees at this location and generates $263,622 in sales (USD). There are 3 companies in the EuroMed Pharma Group B.V. corporate family.
Euromed Pharma is participating in this great event. 3rd Meridian Clinical Trials is focused on challenges competed by small and mid-sized pharmaceutical and biotechnology companies facing while conducting clinical trials. We look forward to supporting new businesses in their quest to better healthcare.
https://www.euromed.it/
Philippines EURO-MED LABORATORIES PHIL., INC. (EURO)
Business Summary
Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacture of pharmaceutical products, such as large and small volume parenterals and other solutions. The Company also manufactures sterile water for injection and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. Its segments are the manufacturing segment, which manufactures pharmaceutical products; the service segment, which operates dialysis centers, and the food service segment, which operates quick service restaurant (QSR), catering, food production and other related services. The Company manufactures parental solutions in glass packaging. The Company's products include Lifeshield Macrodip Non-DEHP, Lifeshield Macrodip with Clave, Lifeshield Blood Set Non-DEHP, Lifeshield Macrodip w/ Clave, Lifeshield Soluset Burette Non-DEHP and Lifeshield Twin Site Non-DEHP. The Company's subsidiaries include Hemotek Renal Center, Inc. and CafeFrance Corp.
https://www.marketscreener.com/quote/stock/EU...1/company/
Euromed
Euromed is a supplier of herbal extracts and natural active substances, used as ingredients in the phyto-pharmaceutical and dietary supplements’ industries. Euromed meets the high standards to merit full certification by the U.S. Food and Drug Administration and Korean FDA, EU GMP guidelines, and other globally recognized high quality certifications.
https://www.riversidecompany.com/investment-p...o/euromed/
Welcome to Euromed Limited
Euromed Limited is actively involved in the business of importation, marketing and distribution of pharmaceutical products. Our goal is clearly defined by our vision to be a leading pharmaceutical company in Nigeria.
https://www.euromedlimited.com/
TOODLES
7
Scroll down for more posts ▼
Top 10 Most Recent News Articles
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Top 5 Most Recently Viewed Articles
TKO Group Announces Strategic Financial Moves TKO Group Holdings, Inc. (NYSE: TKO) has recently made headlines with its announcement of a remarkable share repurchase program amounting to $2 billion. Alongside this significant initiative, the company is introducing a quarterly cash dividend that is projected to reach $75 million. These strategic financial maneuvers reflect...
Continue Reading
Understanding Warner Bros. Discovery's Short Interest Trends Warner Bros. Discovery (WBD) has seen a noteworthy drop in its short percent of float, falling by 11.22% since the last report. Currently, the company reports that there are 101.75 million shares sold short, representing about 4.67% of all available shares for trading. Interestingly, based on the current trading...
Continue Reading
Avobis Bio Unveils Breakthrough in Clinical Trial for AVB-114 Avobis Bio LLC, a pioneering company focused on developing innovative implantable cell therapies, has made a remarkable stride by completing the primary analysis of the STOMP-II randomized clinical trial targeting Crohn's perianal fistulas. This analysis brings with it exciting prospects for FDA interaction and...
Continue Reading
Revolutionizing Fishing with a New Bait Accessory Fishing is more than just a hobby; it's a passion for many outdoor enthusiasts. That's why the recent invention of the E Z BAIT accessory is creating waves in the angling community. Designed for all fishing lovers, it aims to keep your bait right where you need it without missing a beat. Convenience at Your Fingertips...
Continue Reading
Oncoinvent ASA's Periodic Performance Highlights Oncoinvent is making strides in the oncology sector, particularly with its Phase 2 trial for ovarian cancer. This clinical-stage biotechnology company is diligently focusing on expanding its research scope while ensuring sound financial management practices. Their primary product, Radspherin®, is a radiopharmaceutical...
Continue Reading